Idiopathic Pulmonary Fibrosis: Epidemiology, Natural History, Phenotypes
- PMID: 30501130
- PMCID: PMC6313500
- DOI: 10.3390/medsci6040110
Idiopathic Pulmonary Fibrosis: Epidemiology, Natural History, Phenotypes
Abstract
Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial pneumonias. It is characterized by a chronic, progressive, fibrotic interstitial lung disease of unknown cause that occurs primarily in older adults. Its prevalence and incidence have appeared to be increasing over the last decades. Despite its unknown nature, several genetic and environmental factors have been associated with IPF. Moreover, its natural history is variable, but could change depending on the currently suggested phenotypes: rapidly progressive IPF, familial, combined pulmonary fibrosis and emphysema, pulmonary hypertension, and that associated with connective tissue diseases. Early recognition and accurate staging are likely to improve outcomes and induce a prompt initiation of antifibrotics therapy. Treatment is expected to be more effective in the early stages of the disease, while developments in treatment aim to improve the current median survival of 3⁻4 years after diagnosis.
Keywords: comorbidities; evolution; idiopathic pulmonary fibrosis; incidence; prevalence; risk factors.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management.Front Med (Lausanne). 2017 Aug 2;4:123. doi: 10.3389/fmed.2017.00123. eCollection 2017. Front Med (Lausanne). 2017. PMID: 28824912 Free PMC article. Review.
-
Natural history of idiopathic pulmonary fibrosis.Respir Med. 2015 Jun;109(6):661-70. doi: 10.1016/j.rmed.2015.02.002. Epub 2015 Feb 14. Respir Med. 2015. PMID: 25727856 Review.
-
Claims-based Prevalence of Disease Progression among Patients with Fibrosing Interstitial Lung Disease Other than Idiopathic Pulmonary Fibrosis in the United States.Ann Am Thorac Soc. 2022 Jul;19(7):1112-1121. doi: 10.1513/AnnalsATS.202102-222OC. Ann Am Thorac Soc. 2022. PMID: 35015982 Free PMC article.
-
Combined Pulmonary Fibrosis Emphysema: Role of Cigarette Smoking and Pulmonary Hypertension in a Rural Cohort.Int J Chron Obstruct Pulmon Dis. 2021 Jun 21;16:1873-1885. doi: 10.2147/COPD.S307192. eCollection 2021. Int J Chron Obstruct Pulmon Dis. 2021. PMID: 34188464 Free PMC article.
-
Family History of Pulmonary Fibrosis Predicts Worse Survival in Patients With Interstitial Lung Disease.Chest. 2021 May;159(5):1913-1921. doi: 10.1016/j.chest.2021.01.026. Epub 2021 Jan 21. Chest. 2021. PMID: 33484728 Free PMC article.
Cited by
-
Aspergilloma Coexisting With Idiopathic Pulmonary Fibrosis: A Rare Clinical Entity.Cureus. 2024 Apr 29;16(4):e59323. doi: 10.7759/cureus.59323. eCollection 2024 Apr. Cureus. 2024. PMID: 38817531 Free PMC article.
-
Interstitial lung disease: a review of classification, etiology, epidemiology, clinical diagnosis, pharmacological and non-pharmacological treatment.Front Med (Lausanne). 2024 Apr 18;11:1296890. doi: 10.3389/fmed.2024.1296890. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38698783 Free PMC article. Review.
-
Platelet Activating Factor Receptor and Intercellular Adhesion Molecule-1 Expression Increases in the Small Airway Epithelium and Parenchyma of Patients with Idiopathic Pulmonary Fibrosis: Implications for Microbial Pathogenesis.J Clin Med. 2024 Apr 6;13(7):2126. doi: 10.3390/jcm13072126. J Clin Med. 2024. PMID: 38610892 Free PMC article.
-
Multiscale computational model predicts how environmental changes and drug treatments affect microvascular remodeling in fibrotic disease.bioRxiv [Preprint]. 2024 Mar 22:2024.03.15.585249. doi: 10.1101/2024.03.15.585249. bioRxiv. 2024. PMID: 38559112 Free PMC article. Preprint.
-
MAPK phosphatase 1 inhibition of p38α within lung myofibroblasts is essential for spontaneous fibrosis resolution.J Clin Invest. 2024 Mar 21;134(10):e172826. doi: 10.1172/JCI172826. J Clin Invest. 2024. PMID: 38512415 Free PMC article.
References
-
- Travis W.D., Costabel U., Hansell D.M., King T.E., Lynch D.A., Nicholson A.G., Ryerson C.J., Ryu J.H., Selman M., Wells A.U., et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2013;188:733–748. doi: 10.1164/rccm.201308-1483ST. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources